These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1260390)

  • 1. Effect of bromocriptine on plasma growth hormone and glucose tolerance in chronic renal failure.
    Kanis JA; Ledingham JG; Oliver DO; Walton RJ; Nairn IM
    Br Med J; 1976 Apr; 1(6014):879. PubMed ID: 1260390
    [No Abstract]   [Full Text] [Related]  

  • 2. Bromocriptine and TRH-induced growth hormone release in anorexia nervosa.
    Harrower AD; Yap PL; Nairn IM; Strong JA
    Br Med J; 1977 Jul; 2(6081):264. PubMed ID: 406962
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum growth hormone response to bromocriptine during a glucose tolerance test in acromegaly.
    Cassar J; Mashiter K; Sullivan G; Joplin GF
    Acta Endocrinol (Copenh); 1976 May; 82(1):39-46. PubMed ID: 946714
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: Growth, prolactin and growth hormone in lambs treated with CB154.
    Brown WB; Driver PM; Jones R; Forbes JM
    J Endocrinol; 1976 Jun; 69(3):47P. PubMed ID: 985847
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of 2-bromo-alpha-ergocryptine and pimozide on growth hormone secretion in man.
    Dammacco F; Rigillo N; Tafaro E; Gagliardi F; Chetri G; Dammacco A
    Horm Metab Res; 1976 May; 8(3):247-8. PubMed ID: 939473
    [No Abstract]   [Full Text] [Related]  

  • 6. The acute effect of 2-bromo-a-ergocryptine (CB-154) on anterior pituitary hormones and free fatty acids in man.
    Tolis G; Pinter EJ; Friesen HG
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):281-3. PubMed ID: 1165136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutical effects of bromocriptine in 10 acromegalic patients: study of somatotrophic function and glucose tolerance test (author's transl)(proceedings)].
    Fossati P; Asfour M; Brion-Brevan B; Fourlinnie JC; Cappoen JP; Dalle-Furnari MA
    Ann Endocrinol (Paris); 1976; 37(4):299-300. PubMed ID: 1037360
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bromocriptine therapy in acromegaly (author's transl)(proceedings)].
    Schaison G; Mowszowicz I
    Ann Endocrinol (Paris); 1976; 37(4):297-8. PubMed ID: 1037359
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: Bromocritine and serum-growth-hormone levels in diabetes mellitus.
    Cassar J; Edwards R; Mashiter K; Kohner EM
    Lancet; 1975 Jul; 2(7926):181. PubMed ID: 49771
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of bromocriptine on maturity onset diabetes.
    Barnett AH; Chapman C; Gailer K; Hayter CJ
    Postgrad Med J; 1980 Jan; 56(651):11-4. PubMed ID: 6992131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of acromegaly using bromocriptine].
    Köbberling J; Schwinn G; Dirks H
    Dtsch Med Wochenschr; 1975 Jul; 100(29):1540-2. PubMed ID: 1149634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment of acromegaly with lisuride: differences of effect on growth hormone and somatomedin.
    Marek J; Srámková J; Schüllerová M; Stĕpán J; Schreiberová O
    Endokrinologie; 1981 Dec; 78(2-3):175-85. PubMed ID: 7037372
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of acromegaly with bromocryptine.
    Summers VK; Hipkin LJ; Diver MH; Davis JC
    J Clin Endocrinol Metab; 1975 May; 40(5):904-6. PubMed ID: 1127097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of acromegaly by dibromoergocryptine and cyproheptadine (author's transl)(proceedings)].
    Mornex R; Berthezene F; Claustrat B; Fischer C
    Ann Endocrinol (Paris); 1976; 37(4):303-4. PubMed ID: 1037362
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Growth-hormone response to bromocriptine in parkinsonism.
    Shaw KM; Lees AJ; Hayes S; Ross EJ; Stern GM; Thompson BD
    Lancet; 1976 Jan; 1(7952):194. PubMed ID: 54702
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth hormone, insulin, and prolactin secretion in anorexia nervosa and obesity during bromocriptine treatment.
    Harrower AD; Yap PL; Nairn IM; Walton HJ; Strong JA; Craig A
    Br Med J; 1977 Jul; 2(6080):156-9. PubMed ID: 577473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of different neuropharmacologic manipulations to trigger a paradoxical rise of growth hormone after glucose administration in the dog.
    Betti R; Casanueva F; Vellani D; Cocchi D
    Pharmacol Res Commun; 1981 Sep; 13(8):743-53. PubMed ID: 6117088
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of bromocryptine on the secretion of thyrotropic hormone (TSH), prolactin (Pr), human growth hormone (HGH), thyroxine (T4) and triiodothyroxine (T3) in hypothyroidism.
    Felt V; Nedvdková J
    Horm Metab Res; 1977 Jul; 9(4):274-7. PubMed ID: 408253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Bromocriptine and growth hormone.
    Morgan L; Barrett A; Hobbs JR
    Lancet; 1976 Jan; 1(7952):195. PubMed ID: 54704
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of long term bromocriptine treatment on glucose intolerance in acromegaly.
    Chiba T; Chihara K; Minamitani N; Goto B; Kadowaki S; Taminato T; Matsukura S; Fujita T
    Horm Metab Res; 1982 Feb; 14(2):57-61. PubMed ID: 7040191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.